Technology
Applications
Insights
- Molecular Musings
- Health Equities
Contact Us
- Investors & Partnership
About Us
- Company Leadership
- Inside Scoop

Company Leadership

SensTek is led by an eclectic team of engineers, scientists, microbiologists, and medical experts — united by a passion for innovation and impact. With over 190 patents held collectively and an average of 25+ years of experience across technology, bioscience, and product disruption, our team brings deep expertise and bold vision to every challenge we tackle.

Our Leaders

Manny Singh

CEO

Manny Singh

CEO

With over 20 years of experience in technology and semiconductors, Manny is a proven innovator and leader. As a holder of 13 patents, he brings unmatched expertise and a forward-thinking approach to our strategic vision. Graduating with a master’s degree in electrical engineering from San José State University, his accomplishments reflect a profound commitment to excellence and innovation, positioning our company at the forefront of the industry.

Ken Salsman

CTO & Lead Scientist

Ken Salsman

CTO & Lead Scientist

Boasting four decades of pioneering expertise in DeepTech, technology, and MedTech, Ken is a transformative leader and serial entrepreneur. With a remarkable portfolio of over 140 patents, his innovations have consistently pushed the boundaries of what's possible. Ken has excelled in influential roles as Lead Scientist and CTO, underpinning a legacy of groundbreaking advancements and strategic vision. His leadership not only fortifies confidence among investors but also inspires future industry leaders

Richard Robinson

Chief Revenue Officer

Richard Robinson

Chief Revenue Officer

With 40 years of expertise in sales, marketing, business development, and revenue growth, Rich drives success through strategic leadership and innovative approaches. A graduate of San José State University, he leverages extensive industry knowledge to fuel sustained business expansion and profitability. Rich’s proven track record of transforming vision into reality instills confidence among investors and sets a benchmark for aspiring business leaders.

Toni Leinenon

VP of Hardware and Software

Toni Leinenon

VP of Hardware and Software

With 30 years of expertise spanning hardware, software, firmware, and AI/ML development, Toni is a visionary force in automotive, consumer, medical, and industrial sectors. His innovative approach and cross-industry ingenuity consistently drive product excellence and technological advancement. Toni’s sets an inspiring benchmark for future technology leaders, supporting our organization's ongoing growth and success.

Axel Bethke

VP of R&D and Diagnostics

Axel Bethke

VP of R&D and Diagnostics

With 20 years of experience as a microbiologist and research leader in cell biology and bioassay development, Axel is a cornerstone of innovation in diagnostic science. His expert knowledge in LAMP, PCR, ELISA, and other diagnostic techniques empowers pioneering research. As a Postdoctoral Researcher with esteemed institutions like UCSF and Cornell University, Axel consistently demonstrates a commitment to excellence and leadership, serving as a guiding force for aspiring scientists and enhancing our organization’s capabilities.

Our Advisors

Dr. Thomas Krol

PhD

Dr. Thomas Krol

PhD

Dr. Thomas Krol is President of KrolPharma Resources and Chief Development Officer at Novadiol and Axolo Pharma, with over 30 years of leadership in biopharma R&D, innovation, and commercialization. He advanced drug pipelines at Burroughs Wellcome, Marion Labs, and Searle, and negotiated more than $200 million in licensing deals for CyDex, Oakwood Labs, and Novadiol. As Managing Director of human health investments for the $583 million Kansas Bioscience Authority, he has founded and advised life-science startups for more than two decades. Dr. Krol’s work spans 20+ approved biopharma products—including Celebrex®, Geodon®, and Allegra®—across allergy, rare diseases, and beyond. He earned a PharmD from the University of Utah, completed his residency there, and conducted a postdoctoral fellowship at the University of North Carolina.

Dr. Sridhar Kasichainula

PhD

Dr. Sridhar Kasichainula

PhD

Sri K is a senior executive and materials scientist with over 20 years in Silicon Valley, focusing on semiconductors and renewable energy. As founder and CEO of Nimbus Materials, he built an advanced semiconductor company from the ground up. He now advises startups and venture firms, applying deep expertise in engineering, product development, and innovation. He holds 21 patents, has authored 15 peer-reviewed publications, earned a Ph.D. in Materials Science from the University of Arizona, a Private Equity certificate from Wharton, and is a licensed M&A broker in California.

Nicolas Berg

Nicolas Berg

Nicolas Berg is a Swiss venture capitalist and entrepreneur with 41 years of leadership in technology. He co-founded 16 startups—from drug discovery ventures to PCR diagnostics pioneers—and launched two of Switzerland’s leading early-stage VC funds. As an investor in over 50 tech companies and a mentor to more than 10,000 founders, he blends hands-on experience with a journalist’s eye for market trends. Today, he applies that expertise to back founders who solve tough challenges. Outside of work, his passions for ski jumping, music, and the arts fuel creative thinking in every investment.

Dr. Thomas D. Overbay

DVM

Dr. Thomas D. Overbay

DVM

Dr. Thomas D. Overbay is founder and principal of Expedite Animal Health, advising global pharmaceutical, biological, device, and diagnostic companies on business development and product strategy. With a veterinary practice background and nearly 35 years in the animal health industry, he led global business development for a top-5 firm and guided product launches for startups, government labs, and multinationals. His combined expertise in veterinary medicine, technical services, and sales management delivers scientific, financial, and legal insight for successful market entry. Dr. Overbay holds a DVM from the Virginia–Maryland Regional College of Veterinary Medicine.

Professor Christoph A. Meier

Professor Christoph A. Meier

Prof. Christoph A. Meier is a Swiss physician-scientist and healthcare innovator with over 20 years of leadership in internal medicine and value-based care. He directs the Department of Internal Medicine at University Hospital Zürich and sits on global boards including the Novartis Venture Fund and Newsweek Expert Board. From 2016–2020, he served as Chief Medical Officer and deputy CEO at University Hospital Basel, where he championed patient-reported outcomes and strategic growth. Starting August 2025, he will become CEO of C MED CONSULT Ltd, advising on healthcare strategy and biomedicine innovation. He trained at Basel, Geneva, the NIH, and Harvard, and holds board certifications in Internal Medicine and Endocrinology & Diabetology. His engagement with think tanks and federal agencies underpins his mission to advance patient-centered, outcome-driven health systems.

Dr. Sailesh Chittipeddi

PhD

Dr. Sailesh Chittipeddi

PhD

Dr. Sailesh Chittipeddi is a Venture Partner at Novo Tellus Capital Partners in Singapore. He directs board activities at Tessolve (India) and Lantronix (NASDAQ: LTRX) while advising growth-stage tech firms. At Renesas Electronics, he served as Executive Vice President of Global Operations and President of Renesas Electronics America—overseeing manufacturing, supply chain, and development—and as EVP of Industrial IoT and Infrastructure, where he nearly doubled division revenue to $7 billion. Previously, he was EVP of Global Operations and CTO at IDT and CEO of Conexant Systems, with leadership roles at Agere Systems, Lucent Technologies, AT&T Microelectronics, and Bell Labs. He advises startups like Edge Cortix (Japan), Point2 Technology (San Jose), and ObeLabs (Korea). He holds a Ph.D. in Physics from Ohio State University, an MBA from the University of Texas at Austin, 83 U.S. patents, and over 40 technical publications.

Email: info@snstk.com

Please enable JavaScript in your browser to complete this form.

Subscribe to get Latest News from Senstek *

Cookie Policy